Patent infringement: Amgen sues Novartis to block generic osteoporosis, bone cancer drugs Ruchika Sharma3 May 2023 5:30 PM ISTAmgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.
Novartis gets positive CHMP opinion for Cosentyx in adults with hidradenitis suppurativa Ruchika Sharma30 April 2023 10:00 AM ISTCosentyx is the first and only fully human biologic that directly inhibits interleukin-17A, an important cytokine involved in the inflammation of...
Novartis lifts full year earnings on higher prescriptions Ruchika Sharma25 April 2023 11:37 AM ISTFirst-quarter group sales gained 3 percent to $12.95 billion, above an analyst consensus of $12.55 billion, driven by better than expected revenues...
Novartis Millburn facility gets USFDA nod for US commercial production of Pluvicto Ruchika Sharma24 April 2023 2:15 PM ISTUnited States: Novartis has received US Food and Drug Administration (FDA) approval to begin supplying Pluvicto for US commercial use from the...
Novartis bid to revive multiple sclerosis drug Gilenya patent rebuffed by US Supreme Court Ruchika Sharma18 April 2023 12:30 PM ISTThe USFDA in 2010 approved Gilenya to treat relapsing forms of multiple sclerosis.
Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India Ruchika Sharma10 April 2023 3:10 PM ISTGalvus is one of the leading brands in the Dipeptidyl Peptidase-4 (DPP4) space and amongst the prominent brands in the oral diabetic medication...
Novartis Entresto receives positive CHMP opinion for pediatric heart failure Ruchika Sharma2 April 2023 2:00 PM ISTPediatric heart failure represents an important cause of morbidity and mortality in childhood.
Novartis buoyed by trial success in early-stage breast cancer Ruchika Sharma29 March 2023 9:15 AM ISTFrankfurt: Novartis's Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal...
Novartis halts UK trial of anticholesterol drug Leqvio Dr. Nandita Mohan23 March 2023 6:00 PM ISTNovartis said on Wednesday that it had decided not to move forward with ORION-17, the UK-based primary prevention trial originally planned as part of...
Health Bulletin 23/March/2023 Dr. Nandita Mohan23 March 2023 4:25 PM ISTHere are the top health stories for the day:New Bond Policy: Gujarat proposes 1.5 years of mandatory service for doctors completing MBBS, PG...
Novartis not to move ahead with UK trial of anti-cholesterol drug Leqvio Ruchika Sharma22 March 2023 4:00 PM ISTBerlin: Novartis said on Wednesday that it had decided not to move forward with ORION-17, the UK-based primary prevention trial originally...
Novartis secures USFDA nod for Tafinlar plus Mekinist for pediatric brain cancer Ruchika Sharma17 March 2023 2:35 PM ISTLow grade glioma is the most common pediatric brain cancer.
